Merck to Lower Prices on Some Drugs, but Not its Blockbusters

The drugs singled out for discounts include the flagging hepatitis C treatment Zepatier and six drugs that have lost their patent protection.

from NYT > Health https://ift.tt/2LqiJo6
via health&fitness